Published Patent: Chimeric Antisense Oligonucleotides Of Arabinofuranose Analogue And Deoxyribose Nucleotides

File Download
Patent History
  • Application
    US 10/363768
    2003-06-13
  • Publication
    US 20040038399
    2004-02-26
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleChimeric Antisense Oligonucleotides Of Arabinofuranose Analogue And Deoxyribose Nucleotides
Priority Date2001-09-04 PCT/CA2001001252
2000-09-06 US 09/230414P
InventorsLok, CN
Damha, MJ
Parniak, MA
Viazovkina, E
CitationUS Published patent application 20040038399. Washington, DC: US Patent and Trademark Office (USPTO), 2004 [How to Cite?]
AbstractThe Present Invention Relates To Novel Oligonucleotide Chimera Used As Therapeutic Agents To Selectively Prevent Gene Transcription And Expression In A Sequence-Specific Manner. In Particular, This Invention Is Directed To The Selective Inhibition Of Protein Biosynthesis Via Antisense Strategy Using Oligonucleotides Constructed From Arabinonucleotide Or Modified Arabinonucleotide Residues, Flanking A Series Of Deoxyribose Nucleotide Residues Of Variable Length. Particularly This Invention Relates To The Use Of Antisense Oligonucleotides Constructed From Arabinonucleotide Or Modified Arabinonucleotide Residues, Flanking A Series Of Deoxyribose Nucleotide Residues Of Variable Length, To Hybridize To Complementary Rna Such As Cellular Messenger Rna, Viral Rna, Etc.; More Particularly This Invention Relates To The Use Of Antisense Oligonucleotides Constructed From Arabinonucleotide Or Modified Arabinonucleotide Residues, Flanking A Series Of Deoxyribose Nucleotide Residues Of Variable Length, To Hybridize To And Induce Cleavage Of (Via Rnaseh Activation) The Complementary Rna.
DC Field
Value
dc.contributor.inventorLok, CN
dc.contributor.inventorDamha, MJ
dc.contributor.inventorParniak, MA
dc.contributor.inventorViazovkina, E
dc.date.accessioned2007-10-30T07:04:14Z
patents.date.application2003-06-13
dc.date.available2007-10-30T07:04:14Z
patents.date.priority2001-09-04 PCT/CA2001001252
patents.date.priority2000-09-06 US 09/230414P
patents.date.publication2004-02-26
dc.description.abstractThe Present Invention Relates To Novel Oligonucleotide Chimera Used As Therapeutic Agents To Selectively Prevent Gene Transcription And Expression In A Sequence-Specific Manner. In Particular, This Invention Is Directed To The Selective Inhibition Of Protein Biosynthesis Via Antisense Strategy Using Oligonucleotides Constructed From Arabinonucleotide Or Modified Arabinonucleotide Residues, Flanking A Series Of Deoxyribose Nucleotide Residues Of Variable Length. Particularly This Invention Relates To The Use Of Antisense Oligonucleotides Constructed From Arabinonucleotide Or Modified Arabinonucleotide Residues, Flanking A Series Of Deoxyribose Nucleotide Residues Of Variable Length, To Hybridize To Complementary Rna Such As Cellular Messenger Rna, Viral Rna, Etc.; More Particularly This Invention Relates To The Use Of Antisense Oligonucleotides Constructed From Arabinonucleotide Or Modified Arabinonucleotide Residues, Flanking A Series Of Deoxyribose Nucleotide Residues Of Variable Length, To Hybridize To And Induce Cleavage Of (Via Rnaseh Activation) The Complementary Rna.
patents.description.assigneeDamha Masad Jose, ; Parniak Michael A, ; Lok Chun-Nam, ; Viazovkina Ekaterina, ; Mcgill University
patents.description.ccUS
patents.description.countryUnited States of America
patents.description.kindA1
dc.description.naturepublished_or_final_version
dc.format.extent2114508 bytes
dc.format.extent1808 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
patents.identifier.applicationUS 10/363768
dc.identifier.citationUS Published patent application 20040038399. Washington, DC: US Patent and Trademark Office (USPTO), 2004 [How to Cite?]
patents.identifier.publicationUS 20040038399
dc.identifier.urihttp://hdl.handle.net/10722/47016
dc.languageeng
patents.relation.familyAT 293688 (T) 2005-05-15
patents.relation.familyAU 8944801 (A) 2002-03-22
patents.relation.familyAU 2001289448 (B2) 2006-03-16
patents.relation.familyCA 2419563 (A1) 2002-03-14
patents.relation.familyDE 60110244 (T2) 2006-01-19
patents.relation.familyEP 1315807 (A2) 2003-06-04
patents.relation.familyJP 2004507272 (A) 2004-03-11
patents.relation.familyUS 2004038399 (A1) 2004-02-26
patents.relation.familyUS 8178348 (B2) 2012-05-15
patents.relation.familyWO 0220773 (A2) 2002-03-14
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents
dc.titleChimeric Antisense Oligonucleotides Of Arabinofuranose Analogue And Deoxyribose Nucleotides
dc.typePatent
patents.typePatent_published